Group 1 - Smallpox

Definition of Smallpox

  • Cause: Variola Virus

  • Transmission:

    • Primarily through inhalation of contaminated airborne saliva droplets.

    • Contact with infected individuals' scabs/sores.

    • Contact with objects contaminated with the virus.

Historical Importance

  • Noted as one of the deadliest diseases in history.

  • First disease to be eradicated—officially declared eradicated by WHO in May 1980.

  • Milestone: Smallpox is dead!

Effects and Historical Context

  • Smallpox was a catastrophic disease until its eradication in 1980.

  • History:

    • Origins of the disease are unknown.

    • Spread globally through trade and travel.

    • First eradication efforts initiated by the USSR.

    • Notable milestones in history include:

      • Earliest case in Egyptian mummies (1156 BC).

      • Edward Jenner’s development of the first vaccination (1796).

      • Intensified eradication processes leading to global success (1966-1980).

History of Treatment Methods

  • Variolation/Inoculation:

    • Experimentation with survivors indicating immunity similar to that developed against other viruses.

    • Subcutaneous instillation of the virus into non-immune individuals (early 18th century).

    • 2-3% still became infected and died despite variolation.

    • Associated risks of transmitting other diseases such as tuberculosis and syphilis.

  • Coxpox Vaccine:

    • Developed using cowpox, tested on 8-year-old James Phillips, providing a safer and more effective alternative to variolation.

Scientific Significance

  • Pivotal in establishing the fields of Immunology and Virology.

  • Led to the creation and global implementation of public health systems and research organizations.

  • Expanded knowledge of viruses and mechanisms handling them.

  • Vaccination Transformations:

    • First human disease tackled with vaccination.

    • Groundbreaking for modern epidemiological principles.

    • Influenced public health policies and immunization campaigns.

Basic Structure and Spread of Smallpox

  • Characteristics:

    • Member of Orthopoxvirus genus (Poxviridae family).

    • Structure:

      1. Double-stranded DNA genome.

      2. Supporting proteins for uncoating and replication.

      3. Brick-shaped (200-250 nm).

      4. Unique core structure.

      5. Viral envelope from modified Golgi membranes.

  • Transmission:

    • Primarily through fluid contact (saliva, scabs, droplets).

Viral Research and Understanding

  • Established virology as an independent field, advancing knowledge on viral replication.

  • Contributed to immunological milestones, addressing adaptive immune response (antibodies, memory cells).

  • Smallpox genome research elucidated principles of viral evolution, genetic variability, and virus assembly.

  • Catalyzed antiviral drug research, leading to drugs like tecovirimat and brincidofovir.

Medical Significance

  • Historically devastating; only human disease eradicated.

  • Forced evolution of modern inoculation and vaccination practices.

Diagnosis, Treatment, and Challenges

  • Symptoms:

    • High fever (>101°F), headaches, fatigue, muscle pains, nausea, vomiting.

    • Rashes progress to firm vesicles (pustules).

  • Diagnosis often required lab tests as smallpox could mimic chickenpox.

  • Supportive care focused on infection control and wound care.

  • Vaccination emerged as a primary measure for control.

  • Survivors faced scarring and potential blindness.

Historical Approaches to Vaccination

  • Variolation practiced historically, notably in Africa, India, and China (1500s).

  • European adoption followed successful trials despite initial skepticism due to safety concerns.

Evolution of Vaccination

  • Modern smallpox vaccine developed by Edward Jenner using cowpox (1796).

  • The term "vaccination" derived from the Latin word for cowpox.

  • Gradual replacement of inoculation by vaccination; it became illegal in England in 1840.

Modern Preventive Measures and Eradication

  • 19th-century findings indicated that vaccination was not lifelong; revaccination was necessary.

  • 1958: World Health Assembly initiated eradication efforts; WHO conducted campaigns starting in 1967.

  • Eradication achieved by 1980, marking a historic public health milestone.

Ethical Issues Related to Smallpox

  • Concerns regarding informed consent in historical variolation practices.

  • Use of cowpox by Jenner raises ethical questions about lack of consent.

  • Eradication campaigns faced ethical dilemmas balancing individual rights with public health needs.

Post-Eradication Ethical Considerations

  • Historical use in biological warfare highlights the need for careful stockpile management.

  • Current debates influence smallpox vaccination policies, particularly post-9/11 bioterrorism concerns.

Sources